{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:23:17Z","timestamp":1763468597912,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Multiple acyl-CoA dehydrogenase deficiency (MADD), previously called glutaric aciduria type II, is a rare congenital metabolic disorder of fatty acids and amino acids oxidation, with recessive autosomal transmission. The prevalence in the general population is estimated to be 9\/1,000,000 and the prevalence at birth approximately 1\/200,000. The clinical features of this disease are divided into three groups of symptoms linked to a defect in electron transfer flavoprotein (ETF) metabolism. In this case report, we present new pathogenic variations in one of the two ETF protein subunits, called electron transfer flavoprotein alpha (ETFA), in a childhood-stage patient with no antecedent.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A five-year-old child was admitted to the paediatric emergency unit for seizures without fever. He was unconscious due to hypoglycaemia confirmed by laboratory analyses. At birth, he was a eutrophic full-term new-born with a normal APGAR index (score for appearance, pulse, grimace, activity, and respiration). He had one older brother and no parental consanguinity was reported. A slight speech acquisition delay was observed a few months before his admission, but he had no schooling problems. MADD was suspected based on urinary organic acids and plasma acylcarnitine analyses and later confirmed by genetic analysis, which showed previously unreported <jats:italic>ETFA<\/jats:italic> gene variations, both heterozygous (c.354C\u2009&gt;\u2009A (p.Asn118Lys) and c.652G\u2009&gt;\u2009A (p.Val218Met) variations). Treatment was based on avoiding fasting and a slow carbohydrate-rich evening meal associated with L-carnitine supplementation (approximately 100\u2009mg\/kg\/day) for several weeks. This treatment was maintained and associated with riboflavin supplementation (approximately 150\u2009mg\/day). During follow up, the patient exhibited normal development and normal scholastic performance, with no decompensation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This case report describes new pathogenic variations of the <jats:italic>ETFA<\/jats:italic> gene. These compound heterozygous mutations induce the production of altered proteins, leading to a mild form of MADD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12920-020-0665-6","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T14:02:49Z","timestamp":1580306569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene"],"prefix":"10.1186","volume":"13","author":[{"given":"Robin","family":"Chautard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Laroche-Raynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sophie","family":"Lia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Chazelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paco","family":"Derouault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Sturtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Baaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Veauville-Merlli\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Acquaviva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Favreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9291-3795","authenticated-orcid":false,"given":"Pierre-Antoine","family":"Faye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"issue":"2","key":"665_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0009-8981(76)90060-7","volume":"66","author":"H Przyrembel","year":"1976","unstructured":"Przyrembel H, Wendel U, Becker K, Bremer HJ, Bruinvis L, Ketting D, Wadman SK. Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta. 1976;66(2):227\u201339. 1245071.","journal-title":"Clin Chim Acta"},{"key":"665_CR2","first-page":"2357","volume-title":"The metabolic and molecular bases of inherited diseases","author":"FE Frerman","year":"2001","unstructured":"Frerman FE, Goodman SI. Defects of electron transfer flavoprotein and electron transfer flavoprotein\u2013ubiquinone oxidoreductase; glutaric aciduria type II. In: Scriver CR, Beauder AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. p. 2357\u201365.","edition":"8"},{"key":"665_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.nmd.2009.01.008","volume":"19","author":"W-C Liang","year":"2009","unstructured":"Liang W-C, Ohkuma A, Hayashi YK, L\u00f3pez LC, Hirano M, Nonaka I, et al. ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Neuromuscul Disord. 2009;19:212\u20136. https:\/\/doi.org\/10.1016\/j.nmd.2009.01.008.","journal-title":"Neuromuscul Disord"},{"key":"665_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/bf00711782","volume":"18","author":"D Rabier","year":"1995","unstructured":"Rabier D, Bardet J, Parvy P, Poggi F, Brivet M, Saudubray JM, et al. Do criteria exist from urinary organic acids to distinguish beta-oxidation defects? J Inherit Metab Dis. 1995;18:257\u201360. https:\/\/doi.org\/10.1007\/bf00711782.","journal-title":"J Inherit Metab Dis"},{"key":"665_CR5","doi-asserted-by":"publisher","unstructured":"Gr\u00fcnert SC. Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme a dehydrogenase deficiency. Orphanet J Rare Dis. 2014;9. https:\/\/doi.org\/10.1186\/s13023-014-0117-5.","DOI":"10.1186\/s13023-014-0117-5"},{"key":"665_CR6","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awm135","volume":"130","author":"RKJ Olsen","year":"2007","unstructured":"Olsen RKJ, Olpin SE, Andresen BS, Miedzybrodzka ZH, Pourfarzam M, Merinero B, et al. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain. 2007;130:2045\u201354. https:\/\/doi.org\/10.1093\/brain\/awm135.","journal-title":"Brain"},{"issue":"2","key":"665_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/oxfordjournals.jbchem.a124157","volume":"114","author":"K Sato","year":"1993","unstructured":"Sato K, Nishina Y, Shiga K. Electron-transferring flavoprotein has an AMP-binding site in addition to the FAD-binding site. J Biochem. 1993;114(2):215\u201322 ISSN: 1756\u20132651.","journal-title":"J Biochem"},{"issue":"D1","key":"665_CR8","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"25","key":"665_CR9","doi-asserted-by":"publisher","first-page":"14355","DOI":"10.1073\/pnas.93.25.14355","volume":"93","author":"DL Roberts","year":"1996","unstructured":"Roberts DL, Frerman FE, Kim JJ. Three-dimensional structure of human electron transfer flavoprotein to 2.1-a resolution. Proc Natl Acad Sci U S A. 1996;93(25):14355\u201360 PMID: 8962055.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"665_CR10","unstructured":"Jason Vertrees, 2009; https:\/\/pymolwiki.org\/index.php\/InterfaceResidues. Accessed 5 Feb 2019."},{"key":"665_CR11","doi-asserted-by":"publisher","first-page":"W350","DOI":"10.1093\/nar\/gky300","volume":"46","author":"CH Rodrigues","year":"2018","unstructured":"Rodrigues CH, Pires DE, Ascher DB. DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 2018;46:W350\u20135. https:\/\/doi.org\/10.1093\/nar\/gky300.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"665_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1096-7192(03)00024-6","volume":"78","author":"A Curcoy","year":"2003","unstructured":"Curcoy A, Olsen RK, Ribes A, Trenchs V, Vilaseca MA, Campistol J, Osorio JH, Andresen BS, Gregersen N. Late-onset form of beta-electron transfer flavoprotein deficiency. Mol Genet Metab. 2003;78(4):247\u20139 PMID : 12706375.","journal-title":"Mol Genet Metab"},{"key":"665_CR13","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/s0140-6736(03)13105-4","volume":"361","author":"JL Van Hove","year":"2003","unstructured":"Van Hove JL, Gr\u00fcnewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, et al. D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet. 2003;361:1433\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(03)13105-4.","journal-title":"Lancet"},{"key":"665_CR14","doi-asserted-by":"publisher","first-page":"108206","DOI":"10.1016\/j.abb.2019.108206","volume":"679","author":"Maira Silmara de Moraes","year":"2020","unstructured":"Silmara de Moraes M, Guerreiro G, Sitta A, de Moura Coelho D, Manfredini V, Wajner M, et al. Oxidative damage in mitochondrial fatty acids oxidation disorders patients and the in vitro effect of l-carnitine on DNA damage induced by the accumulated metabolites. Arch Biochem Biophys. 2019;679:108206. https:\/\/doi.org\/10.1016\/j.abb.2019.108206","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"665_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.pcl.2017.11.006","volume":"65","author":"A El-Gharbawy","year":"2018","unstructured":"El-Gharbawy A, Vockley J. Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System. Pediatr Clin N Am. 2018;65:317\u201335 W.B. Saunders.","journal-title":"Pediatr Clin N Am"},{"key":"665_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2019.03.015","volume":"703","author":"S Burks","year":"2019","unstructured":"Burks S, Raymick J, Robinson B, Hanig J, Sarkar S. Neuroprotective effects of acetyl-L-carnitine (ALC) in a chronic MPTP-induced Parkinson\u2019s disease mouse model: endothelial and microglial effects. Neurosci Lett. 2019;703:86\u201395.","journal-title":"Neurosci Lett"},{"key":"665_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/1673-5374.265540","volume":"15","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang H. Peripheral nerve injury induced changes in the spinal cord and strategies to counteract\/enhance the changes to promote nerve regeneration. Neural Regen Res. 2020;15:189\u201398 Wolters Kluwer Medknow Publications.","journal-title":"Neural Regen Res"},{"key":"665_CR18","doi-asserted-by":"publisher","unstructured":"Ravikumar S, Prabhu S, Vani R. Effects of L-carnitine on the erythrocytes of stored human blood. Transfus Med. 2019. https:\/\/doi.org\/10.1111\/tme.12645.","DOI":"10.1111\/tme.12645"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-020-0665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-020-0665-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-020-0665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:21:56Z","timestamp":1611793316000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-020-0665-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1186\/s12920-020-0665-6","relation":{},"ISSN":["1755-8794"],"issn-type":[{"type":"electronic","value":"1755-8794"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"12 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained for the work described in this manuscript from the ethics committee of Limoges University Hospital: N\u00b0 308\u20132019-74, as well as the consent of both parents to diffuse this human data. This study was performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardians for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}